No apparent impact of incremental dosing on eliciting dose at double‐blind, placebo‐controlled peanut challenge

Overview of attention for article published in Allergy, October 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

facebook: 1 Facebook page
guideline: 1 clinical guideline source

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 7,916 followers.

No apparent impact of incremental dosing on eliciting dose at double-blind, placebo-controlled peanut challenge https://t.co/O5Ljb4ltvD #PublicaSergas #CHUF

Álvarez García et al. No apparent impact of incremental dosing on eliciting dose at double-blind, placebo-controlled peanut challenge. https://t.co/hnCtkb21iy

No apparent impact of incremental dosing on eliciting dose at double-blind, placebo-controlled peanut challenge https://t.co/O5Ljb4D4Ud #PublicaSergas #CHUF

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.